Quick Answer
XERIANT, INC. reported Research And Development Expense of $69.3 thousand for the year ending 2025.
- XERIANT, INC. showed a decrease of -64.7% in Research And Development Expense from 2024 to 2025.
- This data is from XERIANT, INC.'s annual report (Form 10-K), filed with the SEC on October 2, 2025.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2018: $2.0 thousand | Q1 2019: $2.9 thousand | Q3 2019: $6.3 thousand | Q4 2019: $0.00 | Q1 2020: $0.00 | Q3 2020: $0.00 | Q4 2020: $0.00 | Q1 2021: $0.00 | Q3 2021: $2.34 million | Q4 2021: $2.86 million | Q1 2022: $7.6 thousand | Q3 2022: $0.00 | Q4 2022: $0.00 | Q1 2023: $0.00 | Q3 2023: $27.0 thousand | Q4 2023: $52.8 thousand | Q1 2024: $67.5 thousand | Q3 2024: $26.6 thousand | Q4 2024: $15.00 | Q1 2025: $30.2 thousand | Q3 2025: $54.0 thousand | Q4 2025: $16.3 thousand.
- Over the full 7 years of available data (2019 to 2025), XERIANT, INC.'s Research And Development Expense has grown by 726.3%.
- Historical annual values: Fiscal year 2025: $69.3 thousand | Fiscal year 2024: $196.4 thousand | Fiscal year 2023: $0.00 | Fiscal year 2022: $5.27 million | Fiscal year 2021: $373.1 thousand | Fiscal year 2020: $6.4 thousand | Fiscal year 2019: $8.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: